InvestorsHub Logo
Followers 826
Posts 119569
Boards Moderated 14
Alias Born 09/05/2002

Re: ghmm post# 241

Wednesday, 11/12/2008 2:00:48 PM

Wednesday, November 12, 2008 2:00:48 PM

Post# of 746
>Let me know if there is any additional info you need.<

How can an investor handicap the upcoming Pirfenidone results based on Japanese data? What are the salient differences in trial design? T.i.a.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”